ReviewAnnual review of biomedical engineering2022

Technologies to Assess Drug Response and Heterogeneity in Patient-Derived Cancer Organoids.

Melissa C Skala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.